Form4insider filings, from the source

SEC Form 4 · accession 0001209191-17-063673

SPECTRUM PHARMACEUTICALS INC · SPPI

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Rajesh C Shrotriya M.D.
Officer — Chairman & CEO · Director
Period of report
Nov 30, 2017
Accepted (ET)
Dec 4, 2017 · 7:42 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000831547

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common Stock, $0.001 par valueF1Nov 30, 2017M100,000$3.15A214,684IBy Shrotriya Gift Trust
Common Stock, $0.001 par valueF2Nov 30, 2017F16,545$19.04D198,139IBy Shrotriya Gift Trust
Common Stock, $0.001 par valueF3Nov 30, 2017F27,666$19.04D170,473IBy Shrotriya Gift Trust
Common Stock, $0.001 par valueF4Nov 30, 2017G27,666$19.04D1,829,047D
Common Stock, $0.001 par valueholding———498,894IBy CS Family Trust
Common Stock, $0.001 par valueholding———28,907IBy 401(k) Plan
Common Stock, $0.001 par valueholding———9,523IBy Spouse
Common Stock, $0.001 par valueholding———68,575IBy Shrotriya Family Foundation

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Stock Option Exercise (Right to Buy)$3.15Nov 30, 2017M100,000DDec 6, 2010Dec 6, 2017Common Stock100,0000I

Explanation of responses